Adage Capital Partners GP »

Soleno Therapeutics shares owned by Adage Capital Partners GP

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Adage Capital Partners GP from 13F filings

Historical chart of Adage Capital Partners GP investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Adage Capital Partners GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Adage Capital Partners GP

Quarter filed Position value Share count Share price at filing
2024-03-31 $83M 1.9M 42.80
2023-09-30 $39M 1.3M 29.51

More positions owned by Adage Capital Partners GP

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Hess (HES)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Tesla Motors (TSLA)
Merck & Co (MRK)
Abbvie (ABBV)

View all positions for Adage Capital Partners GP

Top funds holding Soleno Therapeutics

Vivo Capital
Carlyle
Perceptive Advisors
Henderson Group
Nantahala Capital Management
Adage Capital Partners GP
Vanguard Group
Frazier Life Sciences Management
venBio Select Advisor
Ikarian Capital
Pictet Asset Management Holding SA
BlackRock
Emerald Advisers
Susquehanna International
Emerald Mutual Fund Advisers, Trust

View all funds holding Soleno Therapeutics